市場調査レポート
商品コード
1448379
シングルユースアセンブリの世界市場規模、シェア、成長分析:製品別、用途別、ソリューション別 - 産業予測(2024~2031年)Global Single-Use Assemblies Market Size, Share, Growth Analysis, By Product(Bag Assemblies, 2D bag assemblies), By Application(Filtration, Cell Culture & Mixing), By Solution(Customized Solutions, and Standard Solutions) - Industry Forecast 2024-2031 |
シングルユースアセンブリの世界市場規模、シェア、成長分析:製品別、用途別、ソリューション別 - 産業予測(2024~2031年) |
出版日: 2024年03月04日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
世界のシングルユースアセンブリの市場規模は、2022年に27億米ドルとなり、2023年の32億1,000万米ドルから、2031年までには127億3,000万米ドルに成長し、予測期間(2024~2031年)のCAGRは18.80%で成長する見通しです。
シングルユースアセンブリには、組み立て済みのプラスチック製流体経路や自己充足型製品が含まれ、さまざまな標準コンポーネントを組み合わせることによって作成されます。一般的なコンポーネントには、サンプリングボトル、フィルター、チューブ、逆止弁、クランプ、滅菌コネクター、継手、シールなどがあります。拡大する生物製剤市場は、バイオプロセスにおける継続的な技術進歩とともに、バイオ医薬品の研究開発(R&D)を著しく後押ししています。多様な受託製造機関(CMO)によるシングルユースアセンブリの広範な採用は、当面業界の成長を促進すると予想されます。しかし、溶出性物質や抽出性物質、廃棄物管理、マルチユースシステムの利用可能性に関する規制上の考慮事項が、シングルユースアセンブリの普及を抑制する可能性があります。COVID-19の出現は、使い捨て技術が治療薬やワクチンの迅速な生産と開発を促進し、精度と効率を向上させるため、このようなアセンブリの需要をさらに加速させています。特筆すべき例として、Entegris, Inc.のAramusシングルユースバッグアセンブリがあり、保存のために超低温を必要とするCOVID-19ワクチンの保存に利用されています。がんと感染症の流行が増加していることが、診断と治療のための新規生物製剤の生産を促進しています。気候変動や都市化などの要因に起因するがん患者や下気道感染症、HIVなどの感染症の増加は、業界の見通しを高めています。ModernaのmRNAベースのHIVワクチン臨床試験に代表される革新的なワクチン開発は、生物製剤分野における最先端技術の極めて重要な役割を強調しています。パンデミックの可能性を秘めた新興感染症に対処するための共同努力は、新規ワクチンの代替品に向けた推進力をさらに強調しています。
Global Single-Use Assemblies Market size was valued at USD 2.7 billion in 2022 and is poised to grow from USD 3.21 billion in 2023 to USD 12.73 billion by 2031, growing at a CAGR of 18.80% during the forecast period (2024-2031).
Single-use assemblies encompass pre-assembled plastic fluid pathways and self-contained products, created by combining various standard components that are often ready for immediate use and gamma irradiated to ensure sterility. Common components include sampling bottles, filters, tubing, check valves, clamps, sterile connectors, fittings, and seals. The expanding biologics market, along with ongoing technological advancements in bioprocessing, has significantly boosted biopharmaceutical Research and Development (R&D). The widespread adoption of single-use assemblies by diverse Contract Manufacturing Organizations (CMOs) is expected to drive industry growth in the foreseeable future. However, regulatory considerations related to leachable and extractables, waste management, and the availability of multi-use systems may restrain the widespread adoption of single-use assemblies. The emergence of COVID-19 has further accelerated the demand for such assemblies, as disposable technology facilitates rapid production and development of therapies and vaccines, improving precision and efficiency. A notable example is Entegris, Inc.'s Aramus single-use bag assembly, utilized for storing COVID-19 vaccines requiring ultra-low temperatures for preservation. The increasing prevalence of cancer and infectious diseases is driving the production of novel biologics for diagnosis and treatment. The rise in cancer cases and infectious diseases such as lower respiratory infections and HIV, attributed to factors like climate shifts and urbanization, enhances the industry's prospects. Innovative vaccine developments, exemplified by Moderna's mRNA-based HIV vaccine clinical trial, underscore the pivotal role of cutting-edge technologies in the biologics arena. Collaborative efforts to address emerging infectious diseases with pandemic potential further emphasize the push towards novel vaccine alternatives.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single-Use Assemblies Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Single-Use Assemblies Market Segmental Analysis
The Global Single-Use Assemblies Market is segmented on the basis of Product, Application, Solution, End - Use, Region. By Product, the market is segmented into Bag Assemblies, 2D bag assemblies, 3D bags assemblies, Filtration Assemblies, Others. By Application, the market is segmented into Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish Applications, Others. By End - User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs. By Solution, the market is segmented into Customized Solutions, and Standard Solutions. By Region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Drivers of the Global Single-Use Assemblies Market
The use of single-use assemblies reduces the potential for cross-contamination, thereby elevating the safety and quality of products. This disposability feature minimizes the risk associated with reusing components, ensuring a higher level of product integrity.
Restraints in the Global Single-Use Assemblies Market
Single-use assemblies inherently lack reusability, potentially leading to elevated long-term operational expenses and the generation of unnecessary waste.
Market Trends of the Global Single-Use Assemblies Market
Single-Use Assemblies are gaining widespread acceptance in the pharmaceuticals, biotechnology, and food processing sectors owing to their versatile nature, lower risk of contamination, and enhanced operational efficiency.